2017 News Releases

Webcast ImageWebcast
Q3 2017 Surmodics, Inc. Earnings Conference Call (Replay)
08/03/17 at 7:30 a.m. CT
Q3 2017 Surmodics, Inc. Earnings Conference Call
Thursday, August 3, 2017 7:30 a.m. CT  
Webcast PresentationHelp Help
Click here for webcast
Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
08/03/17Surmodics Reports Third Quarter Fiscal 2017 Results and Updates Fiscal 2017 Guidance
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Aug. 3, 2017-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2017 third quarter, ended June 30, 2017. Third Quarter Fiscal 2017 Highlights FDA approves 446 patient SurVeil® DCB Pivotal Study Total Revenue of $17.8 Million EP... 
Printer Friendly Version
07/26/17Surmodics Receives IDE Approval to Initiate Pivotal Trial of the SurVeil™ Drug-Coated Balloon
Study compares SurVeil™ DCB to Medtronic IN.PACT® Admiral® DCB SurVeil DCB design includes new proprietary coating for interventional treatment of PAD EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Jul. 26, 2017-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced it has received an investigational device exemption (IDE) from the U.S. Food and Drug Admin... 
Printer Friendly Version
07/25/17Surmodics to Webcast Third Quarter 2017 Earnings Conference Call on August 3
Webcast is Live at 7:30 a.m. (CT) EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Jul. 25, 2017-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its third quarter fiscal 2017 conference call on Thursday, August 3, at 7:30 a.m. CT (8:30 a.m. ET). The Company will issue an earnings news release earlier that morning. ... 
Printer Friendly Version
05/22/17Surmodics to Present at Upcoming Investor Conferences
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--May 22, 2017-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that Gary Maharaj, president and chief executive officer, and Andy LaFrence, vice president of finance and information systems and chief financial officer, will be attending two upcoming investor conferences. On Wednesday, May 24, 2017, at ... 
Printer Friendly Version
04/27/17Surmodics Reports Second Quarter Fiscal 2017 Results, Updates Fiscal 2017 Financial Guidance
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Apr. 27, 2017-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2017 second quarter, ended March 31, 2017. Second Quarter Fiscal 2017 Financial Highlights Total Revenue of $17.5 Million, up 5% year over year; Medical Device revenue increases 10% ... 
Printer Friendly Version
04/18/17Surmodics to Webcast Second Quarter 2017 Earnings Conference Call on April 27
Webcast is Live at 7:30 a.m. (CT) EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Apr. 18, 2017-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its second quarter fiscal 2017 conference call on Thursday, April 27, at 7:30 a.m. CT (8:30 a.m. ET). The Company will issue an earnings news release earlier that morning. ... 
Printer Friendly Version
04/17/17Surmodics Appoints Lisa Wipperman Heine to Its Board of Directors
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Apr. 17, 2017-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced the addition of Lisa Wipperman Heine to the Company’s Board of Directors, effective on April 12, 2017. Ms. Wipperman Heine has spent over 25 years in leadership positions in the medical device industry. She is currently the Chief Operating ... 
Printer Friendly Version
03/14/17Surmodics to Present at Oppenheimer Healthcare Conference
Webcast is Live on Tuesday, March 21, at 10:55 a.m. (ET) EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Mar. 14, 2017-- Surmodics, Inc. (Nasdaq:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that Gary Maharaj, president and chief executive officer, and Andy LaFrence, vice president of finance and information systems and chief financial officer, will make a presentation to the invest... 
Printer Friendly Version
02/09/17Surmodics Announces 2017 Annual Shareholders Meeting
Virtual Meeting on February 14 at 4:00 p.m. (CT) EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Feb. 9, 2017-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that its virtual Annual Meeting of Shareholders will be held on Tuesday, February 14, at 4:00 p.m. CT (5:00 p.m. ET). Gary Maharaj, chief executive officer, and Sue Knight, chair of the b... 
Printer Friendly Version
02/02/17Surmodics Reports First Quarter Fiscal 2017 Results
GAAP Revenue of $17.8 Million, up 7%; Medical Device increase 12% GAAP EPS of $0.17, Non-GAAP EPS of $0.19 Raises Revenue and EPS Guidance EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Feb. 2, 2017-- Surmodics, Inc. (Nasdaq:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2017 first quarter, ended December 31, ... 
Printer Friendly Version
01/24/17Surmodics to Webcast First Quarter 2017 Earnings Conference Call on February 2
Webcast is Live at 7:30 a.m. (CT) EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Jan. 24, 2017-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its first quarter fiscal 2017 conference call on Thursday, February 2, at 7:30 a.m. CT (8:30 a.m. ET). The Company will issue an earnings news release earlier that morning. ... 
Printer Friendly Version
SRDX (Common Stock)
ExchangeNASDAQ
Price$25.05
Change (%) Stock is Up 0.20 (0.80%)
Volume42,843
Data as of 08/18/17
4:00 p.m. ET
Minimum 20 minute delay
Refresh quote